NYSEARCA:GRN

iPath Series B Carbon ETN (GRN) Price, Holdings, & News

$27.91
+0.36 (+1.31%)
(As of 11:51 AM ET)
Today's Range
$27.91
$28.20
50-Day Range
$21.69
$28.83
52-Week Range
$20.09
$37.49
Volume
3,031 shs
Average Volume
4,714 shs
Market Capitalization
$82.00 million
Assets Under Management
$28.60 million
Dividend Yield
0.00%
Net Expense Ratio
0.75%
GRN stock logo

About iPath Series B Carbon ETN (NYSEARCA:GRN)

The iPath Series B Carbon Exchange-Traded Notes (GRN) is an exchange-traded fund that is based on the Barclays Global Carbon II TR USD index. The fund is an ETN that tracks a liquidity-weighted index of carbon-related credit plans. The index holds December futures contracts on EUAs and CERs. GRN was launched on Sep 10, 2019 and is issued by iPath.

GRN Stock Price History

GRN ETF News Headlines

The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way
See how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.
Bergman & Beving AB Series B
The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way
See how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.
See More Headlines
Receive GRN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iPath Series B Carbon ETN and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
Barclays Capital
Fund Name
iPath Series B Carbon ETN
Tax Classification
Exchange-Traded Note
Current Symbol
NYSEARCA:GRN
Inception Date
9/11/2019
Fund Manager
N/A

Fund Focus

Asset Class
Equity
Benchmark
Barclays Global Carbon II TR USD Index
Category
Strategy
Focus
Theme
Development Level
Developed Markets
Region
Global
Number of Holdings
0

Fund Statistics

Assets Under Management
$28.60 million
Average Daily Volume
$0.00
Discount/Premium
-0.15%

Administrator, Advisor and Custodian

Administrator
N/A
Advisor
N/A
Custodian
N/A
Distributor
N/A
Transfer Agent
N/A
Trustee
N/A
Lead Market Maker
Jane Street

Miscellaneous

Beta
N/A
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

iPath Series B Carbon ETN Expenses

TypeGRNTheme ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.00%0.57%0.54%0.51%0.51%
Other Expenses0.00%0.72%0.54%0.64%0.58%
Total Expense0.00%0.72%0.70%0.74%0.70%
Fee Waiver0.00%-0.76%-0.55%-0.68%-0.57%
Net Expense0.75%0.59%0.60%0.58%0.58%

iPath Series B Carbon ETN (GRN)


GRN ETF - Frequently Asked Questions

How have GRN shares performed in 2024?

iPath Series B Carbon ETN's stock was trading at $30.68 at the beginning of 2024. Since then, GRN stock has decreased by 9.0% and is now trading at $27.91.
View the best growth stocks for 2024 here
.

What does GRN invest in?

iPath Series B Carbon ETN is a equity fund issued by Barclays Capital. GRN focuses on theme investments and follows the Barclays Global Carbon II TR USD Index. The fund's investments total to approximately $28.60 million assets under management.

What other stocks do shareholders of iPath Series B Carbon ETN own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iPath Series B Carbon ETN investors own include Synopsys (SNPS), Sondrel (SND), Marathon Oil (MRO), Electronic Arts (EA) and

How do I buy shares of iPath Series B Carbon ETN?

Shares of GRN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSEARCA:GRN) was last updated on 5/8/2024 by MarketBeat.com Staff

From Our Partners